List of insiders holdings for Vera Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Longitude Capital Partners IV LLC Longitude Prime Partners LLC Longitude Prime Fund L.P. Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner | 2024-11-04 19:49:25 | 5,184,062 0 | 5,184,062 | Form 13D |
Fordyce Marshall PRESIDENT AND CEO | 2024-11-15 16:05:16 | 4,573,714 222,030 | 4,795,744 | Form 4 |
EMSTER KURT VON Director | 2021-05-18 20:10:03 | 17,828 2,960,231 | 2,978,059 | Form 4 |
Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner | 2024-03-26 19:57:53 | 2,813,837 0 | 2,813,837 | Form 13D |
Sofinnova Venture Partners X L.P. Sofinnova Management X L.P. HEALY JAMES Katabi Maha Sofinnova Management X-A L.L.C. 10% Owner | 2024-03-26 19:57:53 | 2,813,837 0 | 2,813,837 | Form 13D |
COMMODORE CAPITAL LP 10% Owner | 2024-11-14 16:10:28 | 2,475,000 0 | 2,475,000 | Form 13G |
Ares Trading S.A. Merck KGaA MERCK SERONO S.A. 10% Owner | 2024-02-14 15:21:33 | 1,913,501 0 | 1,913,501 | Form 13G |
Carlyle Group Inc. Abingworth LLP Abingworth Bioventures 8 LP Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner | 2023-08-02 17:01:28 | 1,872,764 0 | 1,872,764 | Form 13D |
Brenner Robert Chief Medical Officer | 2024-01-08 08:17:02 | 350,000 0 | 350,000 | Form 4 |
Turner William D. Chief Development Officer | 2024-01-09 16:05:39 | 275,000 0 | 275,000 | Form 4 |
Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR | 2024-05-17 16:21:06 | 179,144 0 | 179,144 | Form 4 |
Carter Jason S Chief Legal Officer | 2024-11-20 16:07:22 | 161,000 0 | 161,000 | Form 4 |
JOHNSON DAVID LEE Chief Operating Officer | 2024-07-03 16:05:19 | 160,000 0 | 160,000 | Form 4 |
Grant Sean CHIEF FINANCIAL OFFICER | 2024-04-05 21:32:12 | 146,509 5,000 | 151,509 | Form 4 |
SEIDENBERG BETH C Director | 2024-10-30 16:06:24 | 131,553 4,012 | 135,565 | Form 4 |
Curley Joanne Chief Development Officer | 2023-08-23 17:57:54 | 26,962 0 | 26,962 | Form 4 |
Oliger Christy J. Director | 2024-06-11 16:16:18 | 25,000 0 | 25,000 | Form 4 |
Cheng Andrew Director | 2024-05-17 16:08:44 | 14,000 0 | 14,000 | Form 4 |
ENRIGHT PATRICK G Director | 2024-05-17 16:10:26 | 14,000 0 | 14,000 | Form 4 |
Hall Kimball Director | 2024-05-17 16:12:06 | 14,000 0 | 14,000 | Form 4 |
Katabi Maha Director | 2024-05-17 16:13:27 | 14,000 0 | 14,000 | Form 4 |
MORRISSEY MICHAEL Director | 2024-05-17 16:14:35 | 14,000 0 | 14,000 | Form 4 |
Morrison Scott W Director | 2024-05-17 16:15:53 | 14,000 0 | 14,000 | Form 4 |
Lin Celia Chief Medical Officer | 2023-08-23 17:59:56 | 11,010 0 | 11,010 | Form 4 |
Wolter Jonathan Chief Financial Officer | 2021-05-13 19:05:22 | 0 0 | 0 | Form 3 |